Financhill
Back

BeiGene Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
43

BGNE
BeiGene

Last Price:
206.47
Seasonality Move:
15.02%
Sell
46

RARE
Ultragenyx Pharmaceutical

Last Price:
52.02
Seasonality Move:
11.62%
Sell
43
BeiGene (BGNE) is a Sell

Is BeiGene a Buy, Sell or Hold?

  • The current BeiGene [BGNE] share price is $216.53. The Score for BGNE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BGNE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $52.80. The Score for RARE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BGNE Stock Price Chart

What is BeiGene's stock price today?

  • The BeiGene share price today is $216.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BGNE is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $52.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight selling pressure.

BGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.16 Buy
Relative Strength Index (14 RSI): 48.21 Sell
Chaikin Money Flow: -60094 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (214.13 - 235.75) Sell
Bollinger Bands (100): (156.36 - 214.9) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 38.95 Sell
Chaikin Money Flow: -138218 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.44 - 56.38) Sell
Bollinger Bands (100): (43.42 - 56.66) Buy

BGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 217.66 Sell
20-day SMA: 227.58 Sell
50-day SMA: 210.74 Buy
200-day SMA: 170.97 Buy
8-day EMA: 218.47 Sell
20-day EMA: 220.26 Sell
50-day EMA: 209.9 Buy
200-day EMA: 184.87 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.34 Sell
20-day SMA: 54.67 Sell
50-day SMA: 55.89 Sell
200-day SMA: 47.69 Buy
8-day EMA: 54.09 Sell
20-day EMA: 54.76 Sell
50-day EMA: 54.11 Sell
200-day EMA: 48.72 Buy

BeiGene Earnings Growth & BGNE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.08 per share, and an increase next year of $4.67 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.

BeiGene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):